Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153594 · ClinicalTrials.gov registry record · Phase 3
Early Re-Intervention Experiment 2
A Phase 3 study, sponsored by Chestnut Health Systems.
- Completed
- Registry status
- Phase 3
- Development phase
- 446
- Enrollment target
NCT01153594 is a Phase 3 study that has completed, run by Chestnut Health Systems. The registered enrollment target is 446 participants.
The verdict
NCT01153594, a Phase 3 study, has completed, sponsored by Chestnut Health Systems.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 446 participants
- Enrollment target
Study Summary
The objective of this study was to evaluate the relative effectiveness of quarterly Recovery Management Checkups (RMC) on long-term outcomes of adult chronic substance users over 4 years.
Interventions
- BEHAVIORAL Recovery Management Checkups (RMC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2004-02 |
| Est. Completion | 2009-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01153594
The ClinicalTrials.gov registry entry for NCT01153594 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 446 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Chestnut Health Systems, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Recovery Management Checkups (RMC) is the first listed.
NCT01153594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01153594 about?
NCT01153594 is a clinical study titled "Early Re-Intervention Experiment 2". The objective of this study was to evaluate the relative effectiveness of quarterly Recovery Management Checkups (RMC) on long-term outcomes of adult chronic substance users over 4 years.
What is the current status of trial NCT01153594?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 446 participants. The study started on 2004-02. Estimated completion is 2009-06.
What interventions are being tested in trial NCT01153594?
The interventions under investigation include: Recovery Management Checkups (RMC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01153594?
This trial is sponsored by Chestnut Health Systems, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.